
CCRN Stock Forecast & Price Target
CCRN Analyst Ratings
Bulls say
Cross Country Healthcare is expected to experience growth in the near future due to the expertise of its new CEO and acquisition by Knox Lane, which will provide the company with additional resources and support. Despite facing competition in the medical staffing industry, their strong quarter and changes in revenue projections demonstrate their ability to adapt and continue to generate strong revenue. However, investors should be aware of the potential impact of antitrust delays on the company's stock price.
Bears say
Cross Country Healthcare is facing numerous challenges in the healthcare industry, as evidenced by their recent merger failure and stock price decline. The company's dual revenue stream model has struggled, and there are concerns about potential regulation on their MSP/VMS business model. The current management team is under pressure to drive growth, but the industry challenges they face may hinder their ability to do so.
This aggregate rating is based on analysts' research of Cross Country Healthcare and is not a guaranteed prediction by Public.com or investment advice.
CCRN Analyst Forecast & Price Prediction
Start investing in CCRN
Order type
Buy in
Order amount
Est. shares
0 shares